Second Mayo Clinic Angiogenesis Symposium

Pathways to Therapeutic Angiogenesis in Cancer

October 27-29, 2006

Program Directors:

The main goal of our symposium was to bring together basic science and clinical experts in the field of angiogenesis to facilitate the exchange of ideas and sciences involving basic biology and pathways of angiogenesis and new anti-angiogenic agents that can be used for specific targeting of tumor blood vessels and stroma. Moreover, the clinician scientists presented the results of ongoing clinical trials on anti-angiogenic therapy. Novel genetic and imaging methods to assess tumor vasculature for monitoring the effectiveness of angiogenic response in the pre-clinical and clinical trials were also discussed at this symposium.

Attendance numbers included over 200 researchers and clinicians and 30 world-renowned speakers. This year's Michael A. O'Connor Awardees, Drs. Judah Folkman and Robert Kyle, as well as Drs. Robert Kerbel (Canada) and Harold Dvorak (Harvard) were just a few of the prominent speakers. There were two roundtable sessions focusing on both chronic lymphocytic leukemia and multiple myeloma. The poster sessions included oral presentation highlights from four Young Investigator Award recipients during the banquet on Saturday evening.